Patients in clinical trials in FSHD may have better outcomes than those in natural history studies, regardless of treatment assignment, emphasizing the importance of placebo groups and the need for caution when interpreting the strength results of controlled and uncontrolled trials.
During this study, we noted that instead of interpreting the strength of correlation as an evaluation indicator, it would be better to consider it as different characteristics that depend on the applications.
Therefore, there is no rule for interpreting the strength of R in its application to clinical relevance.
However, caution should be taken in interpreting the strength of our findings, in light of this study's mixed results and methodological limitations.
The association between abnormal SDQ scores and failure to produce 50 words was significant (P < 0.05) for each subscale of the SDQ although the use of multiple comparisons should be noted in interpreting the strength of these associations.
In all three congeneric comparisons, there was some overlap in the 95% confidence set of models (Table 3) indicating that some caution is advisable when interpreting the strength of the differences identified here.
The following guide was used for interpreting the strength of agreement using both the κ and ICC : <0.2 = poor, 0.21-0.40 = fair, 0.41-0.60 = moderate, 0.61-0.80 = substantial, and >0.81 = almost perfect [ 5].
When interpreting the strength of agreement for the kappa coefficient, we used the standards proposed by Landis and Koch [ 35], where a kappa coefficient was: 0 = poor, 0.01 – 0.20 = slight, 0.21– 0.40 = fair, 0.41– 0.60 = moderate, 0.61– 0.80 = substantial, and 0.81 1 = almost perfect.
Guidelines adopted for interpreting the strength of agreement for kappa values were as follows: less than 0.41 represents poor to fair agreement, 0.41 to 0.6 represents moderate agreement, 0.61 to 0.8 represents substantial agreement, and 0.81 to 1 represents almost perfect agreement [ 35].
A built-in sensor then interprets the strength of the charge generated to determine a person's overall glucose levels.
